Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124877) titled 'A Study on the Precision Diagnosis of Prostate Cancer Using Multi-Parameter MRI Radiomics Based on Artificial Intelligence and Deep Learning' on May 19.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking Union Medical College Hospital
Condition:
prostate cancer
Intervention:
Gold Standard:Pathological Diagnosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-01
Target Sample Size: Target condition:450;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3221...